Accelerated Approval Of Lilly’s Alzheimer’s Drug Could Last About 15 Months, CEO Says

 
• By Brenda Sandburg
  
Alzheimer's research
Lilly expects to complete confirmatory trial to support accelerated approval of its Alzheimer's disease drug in 2023 • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D